KianiR, LawdenM, EamesP, CritchleyP, BhaumikS, OdedraS, GumberR: Anti-NMDA-receptor encephalitis presenting with catatonia and neuroleptic malignant syndrome in patients with intellectual disability and autism. Psychiatric Bull: 1-4, 2014.
8.
KumarR, GunaranteD, KhanS, CrawfordK, CookM, TuckR: Acute neuropsychiatric manifestations of anti NMDAR encephalitis. Australasian Psychiatry, 21: 279–281, 2013.
9.
LibaZ, SebronovaV, KomarekV, SedivaA, SedlacekP: Prevalence and treatment of anti-NMDA receptor encephalitis. The Lancet Neurology., 12: 424–425, 2013.
10.
MannA, MachadoNM, LiuN, MazinA, SilverK, AfzalKI: A multidiciplinary approach to the treatment of anti NMDAR antibody encephalitis: A case and review of the literature. Clin Neurosci., 24:2247–2254, 2012.
11.
MatsumotoT, MatsumotoK, KobayashiT, KatoS: Electroconvulsive therapy can improve psychotic symptoms in anti NMDAR encephalitis. Psychiatry Clin Neurosci, 66: 242–246, 2012.
12.
McKeonA: The importance of early and sustained treatment of common autoimmune encephalitis. The Lancet Neurology., 12: 123–124, 2013.
13.
NijmeijerS, BontempsS, NaeijeL, CoutinhoJ: Anti NMDAR encephalitis in a pre-teenage girl: A case report. Eur J Pediatrics., 173:681–683, 2014.
14.
NisijimaK and IshiguroT: Cerebrospinal fluid levels of monoamine metabolites and gamma- aminobutyric acid in neuroleptic malignant syndrome. J Psychiatric Res, 29: 233-244, 1995.
15.
PrussH, DalmauJ, HarmsL, HoltjeM, Ahnert-HilgerG, BorowskiK, StoeckerW, WandingerKP. Retrospective analysis of anti-glutamate receptor (type NMDA) antibodies in patients with encephalitis of unknown origin. Neurology. 75: 1735–1739, 2010.
16.
RahaS, GadgilP, SankhlaC, UdaniV: Nonparaneoplastic Anti NMDAR encephalitis: A case series of four children. Pediatric Neurol, 46: 246–249, 2012.
17.
SansingLH, TuzunE, KoMW, BacconJ, LynchDR. A patient with encephalitis associated with NMDA receptor antibodies. Nature Clin Prac Neurol 3: 291–296, 2007.
18.
TitulaerMJ:. Treatment and prognostic factors for long-term outcome in patients with anti NMDAR encephalitis: An observational cohort study. The Lancet Neurology., 12: 157–165, 2013.
19.
Van de ReitEH, EsseveldMM, CuypersL, SchieveldJN: Anti NMDAR encephalitis: A new, severe and challenging enduring entity. Eur Child Adolesc Psychiatry, 22: 319–323, 2013.
